每经记者|林姿辰 每经编辑|张益铭5月14日,百济神州发布了高瓴资本旗下平台再度减持公司股份的公告,这家陪伴了公司11年、参与8轮融资的核心投资者,不再是公司持股5%以上的股东。此前,百济神州的A股市值一度超过恒瑞医药,被视作A股新“医药一哥”。而且,百济神州在今年一季度实现首次季度GAAP(公认会计原则)盈利,还预计2025年经营利润为正。高瓴资本为何选择在公司即将实现盈利时屡次减持?除了...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.